All Publications

Antiviral Research: Recombinant polyclonal antibody GIGA-2339 potently and pan-genotypically neutralizes hepatitis B virus

Cell Reports Methods: High-throughput specificity profiling of antibody libraries using ribosome display and microfluidics

Antiviral Research: New technologies in therapeutic antibody development: The next frontier for treating infectious diseases

The Journal of Infectious Diseases: A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern

Journal of Clinical Immunology: Sequencing the B Cell Receptor Repertoires of Antibody-Deficient Individuals With and Without Infection Susceptibility

Pathogens: GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2

mAbs: Predicting antibody binders and generating synthetic antibodies using deep learning

BioRxiv: Lack of blocking activity in anti-CTLA-4 antibodies reduces toxicity, but not anti-tumor efficacy

BMC Biology: Single-cell transcriptomics reveals the effect of PD-L1/TGF-β blockade on the tumor microenvironment

Nature Biotechnology: Generation of recombinant hyperimmune globulins from diverse B-cell repertoires

mAbs: Affinity maturation of antibodies by combinatorial codon mutagenesis versus error-prone PCR

Antibodies: Preferential Identification of Agonistic OX40 Antibodies by Using Cell Lysate to Pan Natively Paired, Humanized Mouse-Derived Yeast Surface Display Libraries

mAbs: Antibody repertoire analysis of mouse immunization protocols using microfluidics and molecular genomics

mAbs: A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody library

mAbs: Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomics

mAbs: Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics

For media inquiries, please contact us.